No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ALT Altimmune
- 7.280
- -0.390-5.08%
Trading Dec 30 12:54 ET
517.79MMarket Cap-4.64P/E (TTM)
7.610High7.170Low1.29MVolume7.460Open7.670Pre Close9.39MTurnover1.83%Turnover RatioLossP/E (Static)71.12MShares14.84052wk High3.88P/B513.95MFloat Cap5.27552wk Low--Dividend TTM70.60MShs Float978.000Historical High--Div YieldTTM5.74%Amplitude-1731.000Historical Low7.283Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Jim Cramer on Altimmune, Inc. (ALT): 'Healthcare Is So Out Of Fashion'
Most Shorted Stocks on Wall Street Heading Into 2025: BYND, KSS, GRPN, and More
We're Not Very Worried About Altimmune's (NASDAQ:ALT) Cash Burn Rate
Weight-loss Drugs in 2025, Auto Industry Outlook: Market Domination
B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20
B.Riley Financial Keeps Their Buy Rating on Altimmune (ALT)
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
